Alyeska Investment Group’s NewAmsterdam Pharma NAMS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-114,707
| Closed | -$2.95M | – | 610 |
|
|
2024
Q4 | $2.95M | Sell |
114,707
-193,451
| -63% | -$4.97M | 0.01% | 444 |
|
|
2024
Q3 | $5.12M | Buy |
308,158
+222,517
| +260% | +$3.69M | 0.03% | 354 |
|
|
2024
Q2 | $1.65M | Buy |
85,641
+50,000
| +140% | +$961K | 0.01% | 411 |
|
|
2024
Q1 | $843K | Buy |
+35,641
| New | +$843K | 0.01% | 400 |
|
|
2023
Q4 | – | Sell |
-44,432
| Closed | -$411K | – | 550 |
|
|
2023
Q3 | $411K | Sell |
44,432
-85,115
| -66% | -$787K | ﹤0.01% | 437 |
|
|
2023
Q2 | $1.54M | Buy |
+129,547
| New | +$1.54M | 0.01% | 397 |
|
|
2023
Q1 | – | Sell |
-200,000
| Closed | -$1.89M | – | 492 |
|
|
2022
Q4 | $1.89M | Buy |
+200,000
| New | +$1.89M | 0.02% | 322 |
|